Archive - April 2019
Specialized Metrics to Properly Assess AI-Pharma Startups
Genfit claims FDA breakthrough status for liver disease drug
With Spiriva under pressure, Boehringer moves to bolster pipeline
‘Fingerprint database’ could help pinpoint environmental cancer causes
NICE final guidance published for Cimzia
Public ‘unaware’ they have a choice of hospitals for NHS treatment
PureTech Health, Boehringer Ingelheim enter $26M immuno-oncology deal
Mereo’s shareholders back OncoMed takeover